Cargando…

P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA

Detalles Bibliográficos
Autores principales: Kuang, L., Fang, B., Chen, W., Liu, A., Li, C., Bao, L., Fu, C., Chen, J., Li, H., Pang, Y., Liao, A., Liang, Y., Wei, Y., Li, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430816/
http://dx.doi.org/10.1097/01.HS9.0000846548.89204.ce
_version_ 1784779881327886336
author Kuang, L.
Fang, B.
Chen, W.
Liu, A.
Li, C.
Bao, L.
Fu, C.
Chen, J.
Li, H.
Pang, Y.
Liao, A.
Liang, Y.
Wei, Y.
Li, J.
author_facet Kuang, L.
Fang, B.
Chen, W.
Liu, A.
Li, C.
Bao, L.
Fu, C.
Chen, J.
Li, H.
Pang, Y.
Liao, A.
Liang, Y.
Wei, Y.
Li, J.
author_sort Kuang, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9430816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94308162022-08-31 P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA Kuang, L. Fang, B. Chen, W. Liu, A. Li, C. Bao, L. Fu, C. Chen, J. Li, H. Pang, Y. Liao, A. Liang, Y. Wei, Y. Li, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430816/ http://dx.doi.org/10.1097/01.HS9.0000846548.89204.ce Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Kuang, L.
Fang, B.
Chen, W.
Liu, A.
Li, C.
Bao, L.
Fu, C.
Chen, J.
Li, H.
Pang, Y.
Liao, A.
Liang, Y.
Wei, Y.
Li, J.
P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title_full P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title_fullStr P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title_full_unstemmed P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title_short P920: EFFECTIVENESS AND SAFETY OF SELINEXOR-BASED REGIMEN IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A MULTICENTER REAL-WORLD STUDY FROM CHINA
title_sort p920: effectiveness and safety of selinexor-based regimen in the treatment of relapsed and refractory multiple myeloma: a multicenter real-world study from china
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430816/
http://dx.doi.org/10.1097/01.HS9.0000846548.89204.ce
work_keys_str_mv AT kuangl p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT fangb p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT chenw p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT liua p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT lic p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT baol p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT fuc p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT chenj p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT lih p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT pangy p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT liaoa p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT liangy p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT weiy p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina
AT lij p920effectivenessandsafetyofselinexorbasedregimeninthetreatmentofrelapsedandrefractorymultiplemyelomaamulticenterrealworldstudyfromchina